AdeTherapeutics Inc. Report issue

For profit Phase 1
Founded: Saskatoon SK Canada (2006)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2012
NCT01701193
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

amino acids (Freamine) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pregnancy, Ectopic (Phase 1)

Tissue Adhesions (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2